EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Controlled human infection with Plasmodium falciparum-infected mosquito bites elicits antibodies against mosquito salivary protein SG1L3

Carolina M Andrade iD, Renate C van Daalen, Amanda Fabra-García, Sanne Grievink, Geert-Jan van Gemert, Karina Teelen, Svenja S Hester, Rianne Stoter, Marga van de Vegte-Bolmer, Chris Drakeley, Alfred B Tiono, Robert W Sauerwein und 2 weitere

PLOS Pathogens · 28.10.2026 · 22 (10) · e1014719

DOI: 10.1371/journal.ppat.1014719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 28.10.2026. Verfasst von Carolina M Andrade und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Plasmodium falciparum, Salivary Proteins and Peptides, Malaria, Falciparum, Antibodies, Protozoan. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human malaria infections begin with the injection of Plasmodium sporozoites via mosquito saliva. Whole sporozoite immunizations have been used as a model to study immune responses to malaria parasites, having culminated in circumsporozoite protein (CSP)-targeting vaccines and monoclonal antibodies (mAbs). However, antibody responses targeting non-CSP antigens on the sporozoite surface remain poorly characterized. Here, we isolated single B cells from a human volunteer immunized by Plasmodium falciparum- infected mosquito bites, who had acquired non-CSP-specific antibodies that recognize sporozoites. We identified two mAbs that recognize the surface of P. falciparum sporozoites, but do not bind to CSP. Using immunoprecipitation followed by mass-spectrometry, we found that the target of these mAbs is not a P. falciparum protein but the mosquito salivary protein SG1L3. We observed that recombinant SG1L3 binds to P. falciparum sporozoites. However, the SG1L3-specific mAbs and SG1L3-specific polyclonal antibodies from this volunteer, as well as polyclonal antibodies raised against recombinant SG1L3 in rabbits, fail to block liver stage infection in vitro , making this an unlikely target for functional antibodies. We observed that inhabitants from an area with intense Anopheles exposure in Burkina Faso can have antibodies against SG1L3, and that antibody titers increase with age. In conclusion, we identified the first human mAbs against a mosquito saliva protein that binds to the surface of sporozoites. Future work should assess whether naturally acquired antibodies against this protein may be used as a serological marker of mosquito exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumSalivary Proteins and PeptidesMalaria, FalciparumAntibodies, ProtozoanInsect Bites and StingsInsect ProteinsHumansAnimalsSporozoitesAntibodies, MonoclonalRabbitsProtozoan ProteinsFemale

Substanzen

Salivary Proteins and PeptidesAntibodies, ProtozoanAntibodies, MonoclonalInsect ProteinsProtozoan Proteins

Autor:innen und Institutionen

  • Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.

ORCID-Profile: Carolina M Andrade, Matthijs M Jore

Förderung

  • Bill & Melinda Gates Foundation
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • Bill and Melinda Gates Foundation

Zitieren

APA

Andrade, C. M., van Daalen, R. C., Fabra-García, A., Grievink, S., van Gemert, G. J., Teelen, K., Hester, S. S., Stoter, R., van de Vegte-Bolmer, M., Drakeley, C., Tiono, A. B., Sauerwein, R. W., Bousema, T., & Jore, M. M. (2026). Controlled human infection with Plasmodium falciparum-infected mosquito bites elicits antibodies against mosquito salivary protein SG1L3. PLOS Pathogens, 22(10), e1014719. https://doi.org/10.1371/journal.ppat.1014719

Vancouver

Andrade CM, van Daalen RC, Fabra-García A, Grievink S, van Gemert GJ, Teelen K, et al. Controlled human infection with Plasmodium falciparum-infected mosquito bites elicits antibodies against mosquito salivary protein SG1L3. PLOS Pathogens. 2026;22(10):e1014719. doi:10.1371/journal.ppat.1014719

BibTeX
@article{Andrade2026,
  author = {Andrade, Carolina M and van Daalen, Renate C and Fabra-García, Amanda and Grievink, Sanne and van Gemert, Geert-Jan and Teelen, Karina and Hester, Svenja S and Stoter, Rianne and van de Vegte-Bolmer, Marga and Drakeley, Chris and Tiono, Alfred B and Sauerwein, Robert W and Bousema, Teun and Jore, Matthijs M},
  title = {Controlled human infection with Plasmodium falciparum-infected mosquito bites elicits antibodies against mosquito salivary protein SG1L3},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {10},
  pages = {e1014719},
  doi = {10.1371/journal.ppat.1014719}
}
Kostenlos starten →